Eur Rev Med Pharmacol Sci 2023; 27 (21): 10678-10689
DOI: 10.26355/eurrev_202311_34348

Psychological care over patients with lymphoma and lymphoma survivors

K. Warchoł-Biedermann, E. Mojs, W. Samborski, P. Kotyla

Department of Clinical Psychology, Poznan University of Medical Sciences, Poznań, Poland. k.warchol@pro.onet.pl


Lymphomas are characterized by a relatively favorable prognosis and a good five-year survival rate, but they are associated with increased psychosocial distress. There is insufficient evidence on the efficacy of psychological interventions for lymphoma patients. This review aimed to present the research findings on currently used psychological interventions for (non-) Hodgkin lymphoma patients and survivors. A literature search on English language peer-reviewed original publications on psychological interventions for lymphoma patients published prior to December 2021 was performed in PubMed, Medline, Web of Science, Scopus and ResearchGate. Titles and abstracts were screened for the relevant terms including psychological intervention and psychological management along with (non-) Hodgkin lymphoma. The retrieved articles were evaluated by independent reviewers, the lists of eligible publications were compared, and disagreements were resolved by discussion. Of the 50 publications sought for retrieval, 8 articles were shortlisted based on their content. The papers were classified according to their content and the methodology employed. Research themes including “promoting resilience in lymphoma survivors”, “web-based self-management interventions for patients with lymphoma”, “addressing unmet needs whilst undergoing chemotherapy”, and “mind-body interactive exercise” were identified and presented in this review. As the number of lymphoma survivors is increasing, future research on evidence-based interventions addressing patients’ and survivors’ unmet psychological needs is warranted.

Free PDF Download

To cite this article

K. Warchoł-Biedermann, E. Mojs, W. Samborski, P. Kotyla
Psychological care over patients with lymphoma and lymphoma survivors

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 21
Pages: 10678-10689
DOI: 10.26355/eurrev_202311_34348